Penn Pharma voted Best in Class for Innovation

Pharmaceutical manufacturer Penn Pharma received a prestigious accolade at the annual CMO Leadership Awards, in New York, US, winning Best in Class for Innovation. Based in Tredegar in Blaenau Gwent, South Wales, UK, Penn Pharma delivers integrated drug development, clinical trial supply and manufacturing services to the international healthcare industry.

In 2013, Penn Pharma won three of the five possible CMO Leadership Awards for Innovation, Productivity and Regulatory and this year was entered into the newly introduced Best in Class Award for Innovation. Penn became eligible for this new award after receiving the highest perception score in this important category.

The awards, set up by Life Science Leader, were developed in response to the difficulties readers encountered when vetting CMO partners. It recognises companies that achieve the top 20 percentile in perception scores.

Mike Miller, US business development executive, said: “It was an honour to be invited to participate in an evening that recognises superior performance in the CMO industry.”

 Richard Yarwood, chief executive, added: “We pride ourselves on our commitment to innovation and to be recognised as Best in Class in this category proves that our hard work is being recognised.”

To be entered into these awards based on customer feedback is a great achievement and knowing that we are recognised for our innovation only strengthens our desire to continue to lead new developments in our industry sector.”

Jon Howland, vice president of publishing, Life Science Leader, said: “The CMO Leadership Awards are data driven, taking input from over 10,000 customers of CMO services. The Industry Choice Award recognises the companies that these customers view as being the best in the respective categories. We congratulate the employees of Penn Pharma for being recognised with that honour.”

Penn Pharma Ltd, www.pennpharm.com.